Exact Mass: 416.0565856

Exact Mass Matches: 416.0565856

Found 20 metabolites which its exact mass value is equals to given mass value 416.0565856, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

p-Hydroxymethoxybenzobijuglone

p-Hydroxymethoxybenzobijuglone

C23H12O8 (416.0532152)


   

mollicellin M

mollicellin M

C21H17ClO7 (416.0662762)


A member of the class of depsidones that is 3,4-dihydro-2H,7H-chromeno[7,6-b][1,4]benzodioxepine substituted by a chloro group at position 9, a hydroxy group at position 10, methyl groups at positions 2, 2, 5 and 8, a formyl group at position 11 and oxo groups at positions 4 and 7. Isolated from Chaetomium brasiliense it exhibits antimalarial and cytotoxic activities.

   

(+)-(1R,3R)-palmarumycin BG4

(+)-(1R,3R)-palmarumycin BG4

C20H16O8S (416.0565856)


   

CAY10597

5-chloro-1-[(2-fluorophenyl)methyl]-2,2,5-trioxo-spiro[3H-indole-3,3-pyrrolidine-1(2H)-acetic acid

C20H14ClFN2O5 (416.0575236)


   
   

7-(6-bromohexoxy)-5-hydroxy-2-phenylchromen-4-one

7-(6-bromohexoxy)-5-hydroxy-2-phenylchromen-4-one

C21H21BrO4 (416.06231260000004)


   

2,7,8-triamino-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene-3-carbonitrile

2,7,8-triamino-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene-3-carbonitrile

C18H17BrN4O3 (416.04839519999996)


   

3-[5-(3-nitrobenzoyl)-1,3-dioxoisoindol-2-yl]benzoic acid

3-[5-(3-nitrobenzoyl)-1,3-dioxoisoindol-2-yl]benzoic acid

C22H12N2O7 (416.0644482)


   

Crolibulin

Crolibulin

C18H17BrN4O3 (416.04839519999996)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   

(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

C18H13ClF4N2O3 (416.0550786)


   

5-Hydroxy-desmethylanthrotainin

5-Hydroxy-desmethylanthrotainin

C19H14NO10- (416.0617684)


   

4-[[2-[(2E)-2-[(Z)-2-chloro-3-(4-nitrophenyl)prop-2-enylidene]hydrazinyl]-2-oxoacetyl]amino]benzoic acid

4-[[2-[(2E)-2-[(Z)-2-chloro-3-(4-nitrophenyl)prop-2-enylidene]hydrazinyl]-2-oxoacetyl]amino]benzoic acid

C18H13ClN4O6 (416.05235880000004)


   

2-[(3E)-3-[(5Z)-5-[(6-bromo-1H-indol-3-yl)methylidene]-3,6-dioxopiperazin-2-ylidene]propyl]guanidine

2-[(3E)-3-[(5Z)-5-[(6-bromo-1H-indol-3-yl)methylidene]-3,6-dioxopiperazin-2-ylidene]propyl]guanidine

C17H17BrN6O2 (416.05962819999996)


   
   

BAY-1797

BAY-1797

C20H17ClN2O4S (416.05975120000005)


BAY-1797 is a potent, orally active, and selective P2X4 antagonist, with an IC50 of 211 nM against human P2X4. BAY-1797 displays no or very weak activity on the other P2X ion channels. BAY-1797 shows anti-nociceptive and anti-inflammatory effects[1].